$ADXS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Advaxis, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Advaxis, Inc.. Get notifications about new insider transactions in Advaxis, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 05 2020 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Option Exercise | A | 0.66 | 50,000 | 33,000 | 50,000 | |
| May 05 2020 | ADXS | Advaxis, Inc. | Khleif Samir N | Director | Option Exercise | A | 0.66 | 13,000 | 8,580 | 13,000 | |
| May 05 2020 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Option Exercise | A | 0.66 | 13,000 | 8,580 | 13,000 | |
| May 05 2020 | ADXS | Advaxis, Inc. | Berlin Kenneth A | President and CEO | Option Exercise | A | 0.66 | 50,000 | 33,000 | 50,000 | |
| May 05 2020 | ADXS | Advaxis, Inc. | PATTON JAMES P | Director | Option Exercise | A | 0.66 | 13,000 | 8,580 | 13,000 | |
| May 05 2020 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 0.66 | 13,000 | 8,580 | 13,000 | |
| May 05 2020 | ADXS | Advaxis, Inc. | BERMAN RICHARD J | Director | Option Exercise | A | 0.66 | 13,000 | 8,580 | 13,000 | |
| May 05 2020 | ADXS | Advaxis, Inc. | Gutierrez Andres | Executive Vice Pres ... | Option Exercise | A | 0.66 | 50,000 | 33,000 | 50,000 | |
| Mar 16 2020 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Sell | S | 0.55 | 2,401 | 1,321 | 10,476 | 12.9 K to 10.5 K (-18.65 %) |
| Mar 16 2020 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Sell | S | 0.58 | 200 | 116 | 12,877 | 13.1 K to 12.9 K (-1.53 %) |
| Mar 16 2020 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Sell | S | 0.67 | 399 | 267 | 13,077 | 13.5 K to 13.1 K (-2.96 %) |
| Oct 25 2019 | ADXS | Advaxis, Inc. | Gutierrez Andres | Exec VP, Chief Medi ... | Option Exercise | A | 0.31 | 25,000 | 7,750 | 25,000 | |
| Oct 25 2019 | ADXS | Advaxis, Inc. | BERMAN RICHARD J | Director | Option Exercise | A | 0.31 | 10,000 | 3,100 | 10,000 | |
| Oct 25 2019 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 0.31 | 10,000 | 3,100 | 10,000 | |
| Oct 25 2019 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Option Exercise | A | 0.31 | 25,000 | 7,750 | 25,000 | |
| Oct 25 2019 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Option Exercise | A | 0.31 | 10,000 | 3,100 | 10,000 | |
| Oct 25 2019 | ADXS | Advaxis, Inc. | Khleif Samir N | Director | Option Exercise | A | 0.31 | 10,000 | 3,100 | 10,000 | |
| Oct 25 2019 | ADXS | Advaxis, Inc. | PATTON JAMES P | Director | Option Exercise | A | 0.31 | 10,000 | 3,100 | 10,000 | |
| Oct 25 2019 | ADXS | Advaxis, Inc. | Berlin Kenneth A | President & CEO | Option Exercise | A | 0.31 | 50,000 | 15,500 | 50,000 | |
| Apr 11 2019 | ADXS | Advaxis, Inc. | Gutierrez Andres | Executive Vice Pres ... | Grant | A | 3.71 | 3,750 | 13,928 | 3,750 | 0 to 3.8 K |
| Apr 11 2019 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Buy | P | 3.80 | 3,000 | 11,391 | 13,476 | 10.5 K to 13.5 K (+28.64 %) |
| Apr 11 2019 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Grant | A | 3.68 | 2,500 | 9,200 | 5,833 | 3.3 K to 5.8 K (+75.01 %) |
| Apr 10 2019 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Grant | A | 3.85 | 100 | 385 | 100 | 0 to 100 |
| Apr 10 2019 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Grant | A | 3.86 | 2,900 | 11,194 | 2,900 | 0 to 2.9 K |
| Apr 08 2019 | ADXS | Advaxis, Inc. | Berlin Kenneth A | President & CEO | Grant | A | 3.78 | 800 | 3,024 | 800 | 0 to 800 |
| Apr 08 2019 | ADXS | Advaxis, Inc. | Berlin Kenneth A | President & CEO | Grant | A | 3.78 | 2,100 | 7,936 | 2,100 | 0 to 2.1 K |
| Apr 08 2019 | ADXS | Advaxis, Inc. | Berlin Kenneth A | President & CEO | Grant | A | 3.78 | 1,100 | 4,153 | 1,100 | 0 to 1.1 K |
| Nov 07 2018 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 0.54 | 30,000 | 16,200 | 30,000 | |
| Nov 07 2018 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Option Exercise | A | 0.54 | 125,000 | 67,500 | 125,000 | |
| Nov 07 2018 | ADXS | Advaxis, Inc. | Berlin Kenneth A | President & CEO | Option Exercise | A | 0.54 | 320,000 | 172,800 | 320,000 | |
| Nov 07 2018 | ADXS | Advaxis, Inc. | Khleif Samir N | Director | Option Exercise | A | 0.54 | 25,000 | 13,500 | 25,000 | |
| Nov 07 2018 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Option Exercise | A | 0.54 | 25,000 | 13,500 | 25,000 | |
| Nov 07 2018 | ADXS | Advaxis, Inc. | PATTON JAMES P | Director | Option Exercise | A | 0.54 | 25,000 | 13,500 | 25,000 | |
| Nov 07 2018 | ADXS | Advaxis, Inc. | Gutierrez Andres | Exec VP, Chief Medi ... | Option Exercise | A | 0.54 | 125,000 | 67,500 | 125,000 | |
| Nov 07 2018 | ADXS | Advaxis, Inc. | BERMAN RICHARD J | Director | Option Exercise | A | 0.54 | 25,000 | 13,500 | 25,000 | |
| Nov 07 2018 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Option Exercise | A | 0.54 | 150,000 | 81,000 | 150,000 | |
| Nov 07 2018 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Sell | S | 0.58 | 3,963 | 2,299 | 231,206 | 235.2 K to 231.2 K (-1.69 %) |
| Nov 05 2018 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Sell | S | 0.56 | 8,491 | 4,755 | 235,169 | 243.7 K to 235.2 K (-3.48 %) |
| Sep 13 2018 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Option Exercise | P | 1.50 | 28,333 | 42,500 | 28,333 | |
| Sep 13 2018 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Buy | P | 1.20 | 33,333 | 40,000 | 157,143 | 123.8 K to 157.1 K (+26.92 %) |
| Aug 01 2018 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 1.46 | 1,505 | 2,197 | 243,660 | 242.2 K to 243.7 K (+0.62 %) |
| Jul 02 2018 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 1.45 | 1,516 | 2,198 | 242,155 | 240.6 K to 242.2 K (+0.63 %) |
| Jul 02 2018 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 1.72 | 9,000 | 15,480 | 240,639 | 231.6 K to 240.6 K (+3.89 %) |
| Jul 02 2018 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 1.84 | 5,000 | 9,200 | 231,639 | 226.6 K to 231.6 K (+2.21 %) |
| Jun 27 2018 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Grant | A | 0.00 | 15,000 | 0 | 110,355 | 95.4 K to 110.4 K (+15.73 %) |
| Jun 27 2018 | ADXS | Advaxis, Inc. | BERMAN RICHARD J | Director | Grant | A | 0.00 | 5,000 | 0 | 55,669 | 50.7 K to 55.7 K (+9.87 %) |
| Jun 27 2018 | ADXS | Advaxis, Inc. | PATTON JAMES P | Director | Grant | A | 0.00 | 25,000 | 0 | 286,749 | 261.7 K to 286.7 K (+9.55 %) |
| Jun 14 2018 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Grant | A | 1.71 | 5,000 | 8,550 | 95,355 | 90.4 K to 95.4 K (+5.53 %) |
| Jun 13 2018 | ADXS | Advaxis, Inc. | Berlin Kenneth A | President & CEO | Grant | A | 1.84 | 15,000 | 27,600 | 265,000 | 250 K to 265 K (+6.00 %) |
| Jun 13 2018 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Grant | A | 1.89 | 5,000 | 9,450 | 5,000 | 0 to 5 K |
| Jun 13 2018 | ADXS | Advaxis, Inc. | PATTON JAMES P | Director | Grant | A | 1.84 | 50,000 | 92,000 | 261,749 | 211.7 K to 261.7 K (+23.61 %) |
| Jun 13 2018 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Grant | A | 1.84 | 6,802 | 12,516 | 90,355 | 83.6 K to 90.4 K (+8.14 %) |
| Jun 13 2018 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Grant | A | 1.85 | 3,198 | 5,916 | 83,553 | 80.4 K to 83.6 K (+3.98 %) |
| Jun 08 2018 | ADXS | Advaxis, Inc. | Henderson Molly | Executive Vice Pres ... | Option Exercise | A | 1.71 | 250,000 | 427,500 | 250,000 | |
| Jun 01 2018 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 1.82 | 1,765 | 3,212 | 226,639 | 224.9 K to 226.6 K (+0.78 %) |
| May 02 2018 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 1.60 | 1,374 | 2,198 | 224,874 | 223.5 K to 224.9 K (+0.61 %) |
| Apr 25 2018 | ADXS | Advaxis, Inc. | Gutierrez Andres | Exec VP, Chief Medi ... | Option Exercise | A | 1.62 | 250,000 | 405,000 | 250,000 | |
| Apr 25 2018 | ADXS | Advaxis, Inc. | Berlin Kenneth A | President & CEO | Option Exercise | A | 1.62 | 750,000 | 1,215,000 | 750,000 | |
| Apr 25 2018 | ADXS | Advaxis, Inc. | Berlin Kenneth A | President & CEO | Grant | A | 0.00 | 250,000 | 0 | 250,000 | 0 to 250 K |
| Apr 18 2018 | ADXS | Advaxis, Inc. | LOMBARDO ANTHONY A | Interim CEO | Payment of Exercise | F | 1.70 | 11,051 | 18,787 | 81,852 | 92.9 K to 81.9 K (-11.90 %) |
| Apr 03 2018 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Sell | S | 1.62 | 2,193 | 3,553 | 223,500 | 225.7 K to 223.5 K (-0.97 %) |
| Apr 03 2018 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 1.69 | 1,111 | 1,878 | 225,693 | 224.6 K to 225.7 K (+0.49 %) |
| Apr 03 2018 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 1.69 | 1,088 | 1,839 | 226,670 | 225.6 K to 226.7 K (+0.48 %) |
| Feb 02 2018 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 2.96 | 696 | 2,060 | 223,400 | 222.7 K to 223.4 K (+0.31 %) |
| Feb 02 2018 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 2.96 | 580 | 1,717 | 224,593 | 225.2 K to 224.6 K (-0.26 %) |
| Feb 02 2018 | ADXS | Advaxis, Inc. | LOMBARDO ANTHONY A | Interim CEO | Sell | S | 2.93 | 32 | 94 | 92,903 | 92.9 K to 92.9 K (-0.03 %) |
| Dec 04 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 2.99 | 1,035 | 3,095 | 221,952 | 220.9 K to 222 K (+0.47 %) |
| Dec 04 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 2.99 | 856 | 2,559 | 228,764 | 227.9 K to 228.8 K (+0.38 %) |
| Nov 06 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Option Exercise | A | 3.19 | 100,000 | 319,000 | 100,000 | |
| Nov 06 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Sell | S | 3.30 | 3,723 | 12,286 | 220,917 | 224.6 K to 220.9 K (-1.66 %) |
| Nov 06 2017 | ADXS | Advaxis, Inc. | Khleif Samir N | Director | Option Exercise | A | 3.19 | 25,000 | 79,750 | 25,000 | |
| Nov 06 2017 | ADXS | Advaxis, Inc. | MCKEARN THOMAS J | Director | Option Exercise | A | 3.19 | 25,000 | 79,750 | 25,000 | |
| Nov 06 2017 | ADXS | Advaxis, Inc. | PATTON JAMES P | Director | Option Exercise | A | 3.19 | 25,000 | 79,750 | 25,000 | |
| Nov 06 2017 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Option Exercise | A | 3.19 | 25,000 | 79,750 | 25,000 | |
| Nov 06 2017 | ADXS | Advaxis, Inc. | LOMBARDO ANTHONY A | Interim CEO | Option Exercise | A | 3.19 | 100,000 | 319,000 | 100,000 | |
| Nov 06 2017 | ADXS | Advaxis, Inc. | Ridge Thomas J | Director | Option Exercise | A | 3.19 | 25,000 | 79,750 | 25,000 | |
| Nov 06 2017 | ADXS | Advaxis, Inc. | BERMAN RICHARD J | Director | Option Exercise | A | 3.19 | 25,000 | 79,750 | 25,000 | |
| Nov 06 2017 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 3.19 | 30,000 | 95,700 | 30,000 | |
| Nov 06 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Option Exercise | A | 3.19 | 100,000 | 319,000 | 100,000 | |
| Nov 06 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Sell | S | 3.30 | 3,862 | 12,745 | 227,908 | 231.8 K to 227.9 K (-1.67 %) |
| Nov 02 2017 | ADXS | Advaxis, Inc. | LOMBARDO ANTHONY A | Interim CEO | Sell | S | 3.19 | 24 | 77 | 92,935 | 93 K to 92.9 K (-0.03 %) |
| Nov 02 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Sell | S | 3.19 | 12,625 | 40,274 | 224,640 | 237.3 K to 224.6 K (-5.32 %) |
| Nov 02 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 3.40 | 432 | 1,469 | 237,265 | 236.8 K to 237.3 K (+0.18 %) |
| Nov 02 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Sell | S | 3.19 | 12,734 | 40,621 | 231,770 | 244.5 K to 231.8 K (-5.21 %) |
| Nov 02 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 3.40 | 379 | 1,289 | 244,504 | 244.1 K to 244.5 K (+0.16 %) |
| Oct 12 2017 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 4.30 | 600,000 | 2,580,000 | 4,100,043 | 4.7 M to 4.1 M (-12.77 %) |
| Oct 02 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 4.18 | 511 | 2,136 | 236,833 | 236.3 K to 236.8 K (+0.22 %) |
| Oct 02 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 4.18 | 423 | 1,768 | 244,125 | 243.7 K to 244.1 K (+0.17 %) |
| Sep 26 2017 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 4.00 | 300,000 | 1,200,000 | 4,700,043 | 5 M to 4.7 M (-6.00 %) |
| Sep 26 2017 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 4.38 | 405,323 | 1,775,315 | 5,000,043 | 5.4 M to 5 M (-7.50 %) |
| Sep 26 2017 | ADXS | Advaxis, Inc. | ADAGE CAPITAL PARTNERS GP, L.L ... | 10% Owner | Sell | S | 4.68 | 534,000 | 2,499,120 | 5,405,366 | 5.9 M to 5.4 M (-8.99 %) |
| Sep 05 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 6.81 | 318 | 2,166 | 236,322 | 236 K to 236.3 K (+0.13 %) |
| Sep 05 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 6.81 | 273 | 1,859 | 243,702 | 243.4 K to 243.7 K (+0.11 %) |
| Aug 01 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 6.47 | 335 | 2,167 | 236,004 | 235.7 K to 236 K (+0.14 %) |
| Aug 01 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 6.47 | 280 | 1,812 | 243,429 | 243.1 K to 243.4 K (+0.12 %) |
| Jul 03 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 6.49 | 477 | 3,096 | 235,669 | 235.2 K to 235.7 K (+0.20 %) |
| Jul 03 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 6.49 | 394 | 2,557 | 243,149 | 242.8 K to 243.1 K (+0.16 %) |
| Jul 03 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 6.49 | 742 | 4,816 | 618,352 | 617.6 K to 618.4 K (+0.12 %) |
| Jun 20 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 0.00 | 57,199 | 0 | 235,192 | 178 K to 235.2 K (+32.14 %) |
| Jun 20 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 0.00 | 57,199 | 0 | 242,755 | 185.6 K to 242.8 K (+30.83 %) |
| Jun 20 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 0.00 | 177,102 | 0 | 617,610 | 440.5 K to 617.6 K (+40.20 %) |
| Jun 01 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 8.07 | 265 | 2,139 | 177,993 | 177.7 K to 178 K (+0.15 %) |
| Jun 01 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 8.07 | 219 | 1,767 | 185,556 | 185.3 K to 185.6 K (+0.12 %) |
| Jun 01 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.07 | 421 | 3,397 | 440,508 | 440.1 K to 440.5 K (+0.10 %) |
| May 01 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 0.00 | 57,881 | 0 | 177,728 | 119.8 K to 177.7 K (+48.30 %) |
| May 01 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 8.56 | 250 | 2,140 | 119,847 | 119.6 K to 119.8 K (+0.21 %) |
| May 01 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 0.00 | 142,996 | 0 | 440,087 | 297.1 K to 440.1 K (+48.13 %) |
| May 01 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.56 | 349 | 2,987 | 297,091 | 296.7 K to 297.1 K (+0.12 %) |
| May 01 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 0.00 | 57,881 | 0 | 185,337 | 127.5 K to 185.3 K (+45.41 %) |
| May 01 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 8.56 | 185 | 1,584 | 127,456 | 127.3 K to 127.5 K (+0.15 %) |
| Apr 03 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Sell | S | 8.24 | 2,454 | 20,221 | 119,597 | 122.1 K to 119.6 K (-2.01 %) |
| Apr 03 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 8.17 | 219 | 1,789 | 122,051 | 121.8 K to 122.1 K (+0.18 %) |
| Apr 03 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.17 | 365 | 2,982 | 296,742 | 296.4 K to 296.7 K (+0.12 %) |
| Apr 03 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 8.17 | 194 | 1,585 | 127,271 | 127.1 K to 127.3 K (+0.15 %) |
| Mar 01 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Payment of Exercise | F | 8.79 | 52 | 457 | 121,832 | 121.9 K to 121.8 K (-0.04 %) |
| Mar 01 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 8.79 | 298 | 2,619 | 121,884 | 121.6 K to 121.9 K (+0.25 %) |
| Mar 01 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 8.79 | 104 | 914 | 296,377 | 296.5 K to 296.4 K (-0.04 %) |
| Mar 01 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.79 | 490 | 4,307 | 296,481 | 296 K to 296.5 K (+0.17 %) |
| Mar 01 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Payment of Exercise | F | 8.79 | 61 | 536 | 127,077 | 127.1 K to 127.1 K (-0.05 %) |
| Mar 01 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 8.79 | 263 | 2,312 | 127,138 | 126.9 K to 127.1 K (+0.21 %) |
| Feb 02 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Payment of Exercise | F | 8.96 | 48 | 430 | 121,586 | 121.6 K to 121.6 K (-0.04 %) |
| Feb 02 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 8.96 | 282 | 2,527 | 121,634 | 121.4 K to 121.6 K (+0.23 %) |
| Feb 02 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 8.96 | 97 | 869 | 295,991 | 296.1 K to 296 K (-0.03 %) |
| Feb 02 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.96 | 466 | 4,175 | 296,088 | 295.6 K to 296.1 K (+0.16 %) |
| Feb 02 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Payment of Exercise | F | 8.96 | 56 | 502 | 126,875 | 126.9 K to 126.9 K (-0.04 %) |
| Feb 02 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 8.96 | 250 | 2,240 | 126,931 | 126.7 K to 126.9 K (+0.20 %) |
| Jan 03 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 7.16 | 192 | 1,375 | 295,622 | 295.8 K to 295.6 K (-0.06 %) |
| Jan 03 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 7.16 | 792 | 5,671 | 295,814 | 295 K to 295.8 K (+0.27 %) |
| Jan 03 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Payment of Exercise | F | 7.16 | 93 | 666 | 121,352 | 121.4 K to 121.4 K (-0.08 %) |
| Jan 03 2017 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 7.16 | 476 | 3,408 | 121,445 | 121 K to 121.4 K (+0.39 %) |
| Jan 03 2017 | ADXS | Advaxis, Inc. | Mayes, Gregory T. | Director | Payment of Exercise | F | 7.16 | 119 | 852 | 103,841 | 104 K to 103.8 K (-0.11 %) |
| Jan 03 2017 | ADXS | Advaxis, Inc. | Mayes, Gregory T. | Director | Grant | A | 7.16 | 458 | 3,279 | 103,960 | 103.5 K to 104 K (+0.44 %) |
| Jan 03 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Payment of Exercise | F | 7.16 | 189 | 1,353 | 126,681 | 126.9 K to 126.7 K (-0.15 %) |
| Jan 03 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 7.16 | 427 | 3,057 | 126,870 | 126.4 K to 126.9 K (+0.34 %) |
| Jan 03 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Sell | S | 7.37 | 5,520 | 40,682 | 126,443 | 132 K to 126.4 K (-4.18 %) |
| Jan 03 2017 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 0.00 | 50,000 | 0 | 131,963 | 82 K to 132 K (+61.00 %) |
| Dec 21 2016 | ADXS | Advaxis, Inc. | MCKEARN THOMAS J | Director | Sell | S | 8.08 | 12,316 | 99,513 | 69,804 | 82.1 K to 69.8 K (-15.00 %) |
| Dec 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 8.31 | 89 | 740 | 295,022 | 295.1 K to 295 K (-0.03 %) |
| Dec 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.31 | 455 | 3,781 | 295,111 | 294.7 K to 295.1 K (+0.15 %) |
| Dec 01 2016 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Payment of Exercise | F | 8.31 | 49 | 407 | 120,969 | 121 K to 121 K (-0.04 %) |
| Dec 01 2016 | ADXS | Advaxis, Inc. | PETIT ROBERT | Chief Scientific Of ... | Grant | A | 8.31 | 274 | 2,277 | 121,018 | 120.7 K to 121 K (+0.23 %) |
| Dec 01 2016 | ADXS | Advaxis, Inc. | Mayes, Gregory T. | Chief Business Offi ... | Payment of Exercise | F | 8.31 | 58 | 482 | 103,502 | 103.6 K to 103.5 K (-0.06 %) |
| Dec 01 2016 | ADXS | Advaxis, Inc. | Mayes, Gregory T. | Chief Business Offi ... | Grant | A | 8.31 | 263 | 2,186 | 103,560 | 103.3 K to 103.6 K (+0.25 %) |
| Dec 01 2016 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Payment of Exercise | F | 8.31 | 55 | 457 | 81,963 | 82 K to 82 K (-0.07 %) |
| Dec 01 2016 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Grant | A | 8.31 | 245 | 2,036 | 82,018 | 81.8 K to 82 K (+0.30 %) |
| Nov 07 2016 | ADXS | Advaxis, Inc. | MCKEARN THOMAS J | Director | Option Exercise | A | 7.71 | 25,000 | 192,750 | 25,000 | |
| Nov 07 2016 | ADXS | Advaxis, Inc. | SIDRANSKY DAVID | Director | Option Exercise | A | 7.71 | 30,000 | 231,300 | 30,000 | |
| Nov 07 2016 | ADXS | Advaxis, Inc. | BERMAN RICHARD J | Director | Option Exercise | A | 7.71 | 25,000 | 192,750 | 25,000 | |
| Nov 07 2016 | ADXS | Advaxis, Inc. | APPEL RONI | Director | Option Exercise | A | 7.71 | 25,000 | 192,750 | 25,000 | |
| Nov 07 2016 | ADXS | Advaxis, Inc. | Bonstein Sara | Chief Financial Off ... | Option Exercise | A | 7.71 | 68,906 | 531,265 | 68,906 |